Vancomycin-resistant Staphylococcus aureus epidemiology and demographics
Vancomycin-resistant Staphylococcus aureus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vancomycin-resistant Staphylococcus aureus epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus epidemiology and demographics |
FDA on Vancomycin-resistant Staphylococcus aureus epidemiology and demographics |
CDC on Vancomycin-resistant Staphylococcus aureus epidemiology and demographics |
Vancomycin-resistant Staphylococcus aureus epidemiology and demographics in the news |
Blogs on Vancomycin-resistant Staphylococcus aureus epidemiology and demographics |
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
VISA and VRSA infections are rare. Only sixteen cases of infection caused by VISA (Michigan 1997, New Jersey 1997, New York 1998, Illinois 1999, Minnesota 2000, Nevada 2000, Maryland 2000, and Ohio 2001) and six cases of infection caused by VRSA (Michigan 2002 , Pennsylvania 2002, New York 2004, and 3 from Michigan in 2005) have been reported in the United States.